From: ENT manifestation CCs in tuberculosis: a descriptive study
Sr. no. | Investigation | TB lymphadenitis, % (cases) | TB laryngitis, % (cases) | TB otitis media, % (cases) | TB oral cavity,% (cases) | TB nasal cavity, % (cases) | Total cases diagnosed (%) |
---|---|---|---|---|---|---|---|
1 | Pus for AFB | 5.02% (9) | 88.88% (8) | 100% (6) | 75% (3) | 50% (1) | 27 (13.5%) |
2 | ESR in mm | Â | Â | Â | Â | Â | 200 (100%) |
Below 35 | 42.46% (76) | 22.22% (2) | 50% (3) | 50% (2) | 0 | 83 (41.5%) | |
Below 70 | 49.16% (88) | 55.55% (5) | 33.3% (2) | 25% (1) | 50% (1) | 97 (48.5%) | |
Below 100 | 8.38% (15) | 22.22% (2) | 16.6% (1) | 25% (1) | 50% (1) | 20 (10%) | |
3 | FNAC/biopsy | 100.00% (179) | 77.77% (7) | 33.3% (2) | 50% (2) | 100% (2) | 192 (96%) |
4 | X-ray chest | Â | 100% (9) | Â | Â | Â | 34 (17%) |
Cavity | 8.37% (15) | 55.55% (5) | 3 (50%) | 2 (50%) | 1 (50%) | Â | |
Infiltration | 6.7% (12) | 22.22% (2) | Â | 1 (25%) | Â | Â | |
Hilar enlargement | 8.37% (15) | 22.22% (2) | 1 (16.6%) | Â | Â | Â | |
Pleural effusion | Â | 0% | Â | Â | Â | Â | |
Pneumothorax | Â | 0% | Â | Â | Â | Â | |
5 | X-ray mastoid-sclerosis | Â | Â | 50% (3) | Â | Â | 3 (1.5%) |